DNA Methylation and mRNA Expression of B7-H3 Gene in Ankylosing Spondylitis: A Case-Control Study

Immunol Invest. 2022 Oct;51(7):2025-2034. doi: 10.1080/08820139.2022.2095285. Epub 2022 Jul 4.

Abstract

Background: Ankylosing spondylitis (AS) is a common inflammatory arthritis, with a high prevalence in patients in their mid-20s. Its pathogenesis is not well understood; however, genetic factors likely play a critical role. Epigenetic DNA changes may be involved in the pathogenesis of AS. In this study, we explored the methylation and transcription levels of the B7-H3 gene and its association with AS in an eastern Chinese Han population.

Methods: Peripheral blood of AS patients and healthy controls was used to extract genomic DNA and B7-H3 methylation levels were analyzed using sodium bisulfite followed by multiplex polymerase chain reaction. SPSS software was used to determine the statistical significance of the results.

Results: Hypomethylation of the promoter of the B7-H3 gene was observed in AS patients, whereas the B7-H3 gene expression was significantly enhanced in AS patients.

Conclusion: Epigenetic modifications of B7-H3 were associated with susceptibility to AS. Hypomethylation of the B7-H3 promoter, which leads to B7-H3 overexpression, may be involved in the pathogenesis of AS.

Keywords: Ankylosing spondylitis; B7-H3; DNA methylation; epigenetics; mRNA.

MeSH terms

  • Case-Control Studies
  • DNA / metabolism
  • DNA Methylation
  • Humans
  • RNA, Messenger / genetics
  • Spondylitis, Ankylosing* / genetics

Substances

  • RNA, Messenger
  • DNA